INOVIO PHARMACEUTICALS, INC. Net Income (Loss) Available to Common Stockholders, Diluted
INOVIO PHARMACEUTICALS, INC. (INO) reported Net Income (Loss) Available to Common Stockholders, Diluted of $19.17 million for the 3-month period ending 2020-09-30, per its 10-Q filed 2020-11-09.
Discontinued › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted · last filed 2020-11-09
- INOVIO PHARMACEUTICALS, INC. net income (loss) available to common stockholders, diluted for the quarter ending 2020-09-30 was $19.17M.
- INOVIO PHARMACEUTICALS, INC. net income (loss) available to common stockholders, diluted for the quarter ending 2019-09-30 was -$25.27M.
- INOVIO PHARMACEUTICALS, INC. net income (loss) available to common stockholders, diluted for the quarter ending 2019-06-30 was -$29.39M.
- INOVIO PHARMACEUTICALS, INC. net income (loss) available to common stockholders, diluted for the quarter ending 2018-09-30 was -$25.02M.
| Period end | Net Income (Loss) Available to Common Stockholders, Diluted 3 month | Net Income (Loss) Available to Common Stockholders, Diluted 6 month | Net Income (Loss) Available to Common Stockholders, Diluted 9 month |
|---|---|---|---|
| 2020-09-30 | $19.17M 10-Q · filed 2020-11-09 | -$142.07M 10-Q · filed 2020-11-09 | |
| 2019-09-30 | -$25.27M 10-Q · filed 2020-11-09 | -$54.66M derived: sum of 2 quarters · filed 2020-11-09 | -$81.70M 10-Q · filed 2020-11-09 |
| 2019-06-30 | -$29.39M 10-Q · filed 2019-08-08 | -$58.61M 10-Q · filed 2019-08-08 | |
| 2018-09-30 | -$25.02M 10-Q · filed 2019-11-12 | -$31.91M derived: sum of 2 quarters · filed 2019-11-12 | -$64.01M 10-Q · filed 2019-11-12 |
| 2018-06-30 | -$6.90M 10-Q · filed 2019-08-08 | -$39.12M 10-Q · filed 2019-08-08 | |
| 2017-03-31 | -$23.20M 10-Q · filed 2017-05-10 | ||
| 2016-03-31 | -$8.04M 10-Q · filed 2017-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |